The ability to customize medical choices according to
an individual’s
genetic makeup and biomarker patterns marks a significant advancement
toward overall improved healthcare for both individuals and society
at large. By transitioning from the conventional one-size-fits-all
approach to tailored treatments that can account for predispositions
of different patient populations, nanomedicines can be customized
to target the specific molecular underpinnings of a patient’s
disease, thus mitigating the risk of collateral damage. However, for
these systems to reach their full potential, our understanding of
how nano-based therapeutics behave within the intricate human body
is necessary. Effective drug administration to the targeted organ
or pathological niche is dictated by properties such as nanocarrier
(NC) size, shape, and targeting abilities, where understanding how
NCs change their properties when they encounter biomolecules and phenomena
such as shear stress in flow remains a major challenge. This Review
specifically focuses on vessel-on-a-chip technology that can provide
increased understanding of NC behavior in blood and summarizes the
specialized environment of the joint to showcase advanced tissue models
as approaches to address translational challenges. Compared to conventional
cell studies or animal models, these advanced models can integrate
patient material for full customization. Combining such models with
nanomedicine can contribute to making personalized medicine achievable.